Rankings
▼
Calendar
MNKD FY 2023 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$813M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$199M
+99.4% YoY
Gross Profit
$136M
68.5% margin
Operating Income
$9M
4.4% margin
Net Income
-$12M
-6.0% margin
EPS (Diluted)
$-0.04
Cash Flow
Operating Cash Flow
$34M
Free Cash Flow
-$8M
Stock-Based Comp.
$18M
Balance Sheet
Total Assets
$475M
Total Liabilities
$721M
Stockholders' Equity
-$246M
Cash & Equivalents
$238M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$199M
$100M
+99.4%
Gross Profit
$136M
$42M
+222.2%
Operating Income
$9M
-$64M
+113.5%
Net Income
-$12M
-$87M
+86.3%
← Q4 2022
All Quarters
Q1 2023 →